ASKA Pharmaceutical Holdings regards the return of profits to shareholders as an
important management issue and pays stable dividends.
For FY2022, the Company paid a year-end dividend of 8 yen per share, which, together with the interim dividend of 8 yen per share already paid, resulted in an annual dividend of 16 yen per share.
For FY2023, the Company plans to pay an annual dividend of 40 yen per share (interim dividend: 20 yen per share, year-end dividend: 20 yen per share), which is higher than the previous fiscal year.
Changes in Net Income and Dividends
|
Profit attributable
to owners of
parent
(Millions of yen)
|
Dividends per share (yen) |
Dividend
payout
ratio |
| lnterim |
Year-end |
Total |
FY2023
(Forecast) |
6,200 |
20.00 |
20.00 |
40.00 |
18.1% |
| FY2022 |
4,238 |
8.00 |
8.00 |
16.00 |
10.7% |
| FY2021※1 |
4,290 |
7.00 |
8.00 |
15.00 |
5.3% |
| FY2020 |
2,713 |
7.00 |
7.00 |
14.00 |
14.6% |
| FY2019※2 |
649 |
7.00 |
10.00 |
17.00 |
74.0% |
(Notes)
1. Interim dividend of 7 yen in FY2021 is derived from other capital surpluses and is excluded from the dividend payout ratio.
2. For the fiscal year ending March 31, 2020, we paid a commemorative dividend of 17 yen to celebrate the 100th anniversary of the Company's founding.